184 related articles for article (PubMed ID: 25163699)
1. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.
van Eijk LT; John AS; Schwoebel F; Summo L; Vauléon S; Zöllner S; Laarakkers CM; Kox M; van der Hoeven JG; Swinkels DW; Riecke K; Pickkers P
Blood; 2014 Oct; 124(17):2643-6. PubMed ID: 25163699
[TBL] [Abstract][Full Text] [Related]
2. Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.
Boyce M; Warrington S; Cortezi B; Zöllner S; Vauléon S; Swinkels DW; Summo L; Schwoebel F; Riecke K
Br J Pharmacol; 2016 May; 173(10):1580-8. PubMed ID: 26773325
[TBL] [Abstract][Full Text] [Related]
3. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.
Kemna E; Pickkers P; Nemeth E; van der Hoeven H; Swinkels D
Blood; 2005 Sep; 106(5):1864-6. PubMed ID: 15886319
[TBL] [Abstract][Full Text] [Related]
4. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
Schwoebel F; van Eijk LT; Zboralski D; Sell S; Buchner K; Maasch C; Purschke WG; Humphrey M; Zöllner S; Eulberg D; Morich F; Pickkers P; Klussmann S
Blood; 2013 Mar; 121(12):2311-5. PubMed ID: 23349391
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
[TBL] [Abstract][Full Text] [Related]
6. Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled Trial.
Matzneller P; Strommer S; Drucker C; Petroczi K; Schörgenhofer C; Lackner E; Jilma B; Zeitlinger M
Clin Pharmacol Ther; 2017 Jun; 101(6):773-781. PubMed ID: 27864832
[TBL] [Abstract][Full Text] [Related]
7. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
Brunacci F; Rocha VS; De Carli E; Espósito BP; Ruano R; Colli C
Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
[TBL] [Abstract][Full Text] [Related]
8. Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans.
Kox M; Pompe JC; Gordinou de Gouberville MC; van der Hoeven JG; Hoedemaekers CW; Pickkers P
Shock; 2011 Jul; 36(1):5-11. PubMed ID: 21368716
[TBL] [Abstract][Full Text] [Related]
9. Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia.
Leitner JM; Mayr FB; Firbas C; Spiel AO; Steinlechner B; Novellini R; Jilma B
Int J Immunopathol Pharmacol; 2007; 20(1):25-36. PubMed ID: 17346425
[TBL] [Abstract][Full Text] [Related]
10. The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women.
Stoffel NU; Lazrak M; Bellitir S; Mir NE; Hamdouchi AE; Barkat A; Zeder C; Moretti D; Aguenaou H; Zimmermann MB
Haematologica; 2019 Jun; 104(6):1143-1149. PubMed ID: 30630976
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double-Blinded, Placebo-Controlled CITRIS-AF Pilot Study.
Trankle CR; Puckett L; Swift-Scanlan T; DeWilde C; Priday A; Sculthorpe R; Ellenbogen KA; Fowler A; Koneru JN
J Am Heart Assoc; 2020 Feb; 9(3):e014213. PubMed ID: 32013700
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
13. Running a 100-km ultra-marathon induces an inflammatory response but does not raise the level of the plasma iron-regulatory protein hepcidin.
Kasprowicz K; Ziemann E; Ratkowski W; Laskowski R; Kaczor JJ; Dadci R; Antosiewicz J
J Sports Med Phys Fitness; 2013 Oct; 53(5):533-7. PubMed ID: 23903534
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
Song SN; Iwahashi M; Tomosugi N; Uno K; Yamana J; Yamana S; Isobe T; Ito H; Kawabata H; Yoshizaki K
Arthritis Res Ther; 2013 Oct; 15(5):R141. PubMed ID: 24286116
[TBL] [Abstract][Full Text] [Related]
15. A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?
Tessitore N; Poli A; Bedogna V; Corazza L; Campostrini N; Atti M; Sereni L; Castagna A; Girelli D; Pessolano G; Lupo A
J Nephrol; 2018 Apr; 31(2):297-306. PubMed ID: 28353202
[TBL] [Abstract][Full Text] [Related]
16. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.
Derhaschnig U; Bergmair D; Marsik C; Schlifke I; Wijdenes J; Jilma B
Crit Care Med; 2004 May; 32(5):1136-40. PubMed ID: 15190963
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.
Aksan A; Wohlrath M; Iqbal TH; Dignass A; Stein J
J Crohns Colitis; 2020 Mar; 14(3):316-322. PubMed ID: 31665264
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory state, hepcidin, and anemia in older persons.
Ferrucci L; Semba RD; Guralnik JM; Ershler WB; Bandinelli S; Patel KV; Sun K; Woodman RC; Andrews NC; Cotter RJ; Ganz T; Nemeth E; Longo DL
Blood; 2010 May; 115(18):3810-6. PubMed ID: 20081092
[TBL] [Abstract][Full Text] [Related]
20. Neural circuitry mediating inflammation-induced central pain amplification in human experimental endotoxemia.
Benson S; Rebernik L; Wegner A; Kleine-Borgmann J; Engler H; Schlamann M; Forsting M; Schedlowski M; Elsenbruch S
Brain Behav Immun; 2015 Aug; 48():222-31. PubMed ID: 25882910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
